ConductScience.org, home

Library / Trials

Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use

NCT04181515, Phase 2, Withdrawn, Wayne State University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleUsing rTMS to Explore Neural Mechanisms of Stress-Induced Opioid UseClinicalTrials.gov
NCT numberNCT04181515ClinicalTrials.gov
StatusWithdrawnClinicalTrials.gov
PhasesPhase 2ClinicalTrials.gov
Enrollment0 participants, actualClinicalTrials.gov
Lead sponsorWayne State UniversityClinicalTrials.gov
ConditionsStress, Opioid-use DisorderClinicalTrials.gov
InterventionsPlacebo oral tablet, Yohimbine + Hydrocortisone, sham rTMS, active rTMSClinicalTrials.gov
First posted2019-11-29ClinicalTrials.gov
Last updated2023-04-13ClinicalTrials.gov

Registered outcomes 19

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryAddiction Stroop taskchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)reaction time (msec) measure of cognitive interferenceClinicalTrials.gov
PrimaryDigit Span Taskchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)number of digits recalled, measure of verbal working memoryClinicalTrials.gov
PrimaryWisconsin Card Sorting Taskchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)number of correct items, measures ability to shift set and assesses cognitive flexibilityClinicalTrials.gov
PrimaryMonetary Incentive Delay taskchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)number of rewards received, measure of motivationClinicalTrials.gov
PrimaryDelay Discounting taskchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)rate of monetary discountingClinicalTrials.gov
PrimaryDrug/Money Choice Taskchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)number of hypothetical choices between a constant amount of preferred opioid (relative to money)ClinicalTrials.gov
PrimaryBlood pressurechange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)Systolic/diastolic BP (mm Hg)ClinicalTrials.gov
PrimaryHeart ratechange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)Heart rate (beats/min)ClinicalTrials.gov
PrimarySaliva cortisol levelchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)Saliva cortisol level (µg/dL)ClinicalTrials.gov
PrimarySaliva alpha-amylase levelchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)Saliva alpha-amylase level (U/mL)ClinicalTrials.gov
PrimarySerum prolactin levelchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)Serum prolactin level (pg/dL)ClinicalTrials.gov
PrimarySerum BDNF levelchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)Serum brain derived neurotrophic factor level (pg/dL)ClinicalTrials.gov
PrimaryPositive and Negative Affect Schedule (PANAS) positive affectchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)10-item sub scale score of positive affectClinicalTrials.gov
PrimaryPositive and Negative Affect Schedule (PANAS) negative affectchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)10-item sub scale score of negative affectClinicalTrials.gov
PrimaryState Trait Anxiety Inventorychange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)state anxiety scoresClinicalTrials.gov
PrimaryDesire for Drug Questionnairechange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)opioid craving scoreClinicalTrials.gov
PrimaryOpiate-32 Questionnaire, Agonist scorechange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)total opioid agonist score (16 items)ClinicalTrials.gov
PrimaryOpiate-32 Questionnaire, Withdrawal scorechange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)total opioid withdrawal symptom score (16 items)ClinicalTrials.gov
PrimaryResting-state EEG activationchange from pre- and post-intervention in each of 4 sessions (through study completion, about 1 month total)relative (gamma band ÷ slow band) ratio in electroencephalogram (EEG) power during resting stateClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 5

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Card Sorting Test (Berg)Primary outcomeConductCognition
Delay DiscountingPrimary outcomeConductCognition
Digit Span TestPrimary outcomeConductCognition
Monetary Incentive DelayPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)